Cytek Biosciences has recurring revenue growth, improving margins, and ample cash that should continue compounding ...

Over the past decade, flow cytometry has undergone transformative advancements, notably with the adoption of spectral flow cytometry and the emergence of next-generation imaging cytometers.

Supports ISAC in Mission to Extend Flow Cytometry Reach Worldwide; Unveils Programs Offering Instrument Award and Research ...

Seven early-stage startup companies have been selected to compete for a top prize of $10,000 at the 16th annual SPIE Startup ...

Whether infection of cells by individual virions occurs randomly or if there is some form (s) of competition or cooperativity between individual virions remains largely unknown for most virus-cell ...

As the incidence of cancer rises around the world, the demand for faster, more precise diagnoses is also on the rise. This demand will only intensify over time, as the worldwide incidence of cancer is ...

Jefferies London Healthcare Conference 2025 November 18, 2025 6:00 AM ESTCompany ParticipantsRainer Blair - President, CEO ...

Amid the reduction of various government grant programs and global economic challenges that have tightened research funding, Cytek Biosciences, Inc.

Seven early-stage startup companies have been selected to compete for a top prize of $10,000 at the 16th annual SPIE Startup ...

Cytek Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) (Nasdaq: CTKB), today announced it will report financial results for the third quarter 2025 after market close on Wednesday, November 5, 2025.